UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
    Brian Link
  2. Phase 2 study of the mTOR inhibitor everolimus in combination with bevacizumab in patients with spor(1)
    Mohammed Milhem
  3. Randomized Phase II Study of AB (Abraxane, Bevacizumab) versus Ipilimumab for 1st Line Therapy of Unresectable Stage IV Metastatic Malignant...
    Mohammed Milhem
  4. Association Between Exercise and Centrally-Mediated Pain Perception
    Laura Frey-Law
  5. Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center Randomized Controlled Study Comparing Alternative Antibiotic Regimens in Patients...
    Benjamin Miller MD
  6. Phase III trial of enzalutamide (NSC # 766085) versus enzalutamide, abiraterone and prednisone for c(1)
    Daniel Vaena
  7. Comparator Study of 68Ga-DOTATOC PET/CT with Octreoscan + high-resolution, contrast-enhanced CT for diagnosis and staging in neuroendocrine tumors and other somatostatin receptor positive tumors
    M. Sue O
  8. Single Autologous Transplant Followed by Consolidation and Maintenance for Participants Diagnosed with Multiple Myeloma or a Related Plasma Cell Malignancy
    Guido Tricot
  9. A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma
    Guido Tricot
  10. Collection of Peripheral Blood Stem Cells Following Stimulation with Filgrastim: A study by the National Marrow Donor Program
    Margarida Magalhaes-Silverman
  11. A research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
    Margarida Magalhaes-Silverman
  12. Molecular Markers of Chronic Lymphocytic Leukemia
    Daniel Vaena
  13. A Children
    Ayman El-Sheikh
  14. Consent to Participate in the Neuroendocrine Tumor Registry
    Thomas ODorisio
  15. Renal Tumors Classification, Biology and Banking Study (AREN03B2); 0/30
    Ayman El-Sheikh
  16. A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreductive Sur…
    David Bender
  17. Genetic Epidemiology of B-cell Lymphoproliferative Disorders; SPORE
    Brian Link
  18. A Randomized Trial of Pelvic Irradiation with or without Concurrent Weekly Cisplatin in Patients with Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
    David Bender
  19. Phase I/II Study Epigenetic Modification of Chemosensitivity and Apoptosis in Metastatic Melanoma: Treatment of a Resistant Disease Using Decitabine...
    Mohammed Milhem
  20. A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized P…
    Daniel Vaena

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.